BioArctic AB (publ)
BioArctic AB (publ) develops biological drugs for patients with central nervous system disorders in Sweden. It engages in the research and development of innovative biological drugs, such as antibodies that address high unmet medical needs. The company's therapeutic areas encompass neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease, and other CNS diseases. In addition, … Read more
Market Cap & Net Worth: BioArctic AB (publ) (BRCTF)
BioArctic AB (publ) (PINK:BRCTF) has a market capitalization of $1.34 Billion ($1.34 Billion) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #7295 globally and #3908 in its home market, demonstrating a -0.11% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying BioArctic AB (publ)'s stock price $18.10 by its total outstanding shares 74241489 (74.24 Million).
BioArctic AB (publ) Market Cap History: 2022 to 2025
BioArctic AB (publ)'s market capitalization history from 2022 to 2025. Data shows change from $2.15 Billion to $1.34 Billion (-14.78% CAGR).
BioArctic AB (publ) Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how BioArctic AB (publ)'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
4.97x
BioArctic AB (publ)'s market cap is 4.97 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $2.15 Billion | $228.29 Million | -$11.18 Million | 9.42x | N/A |
| 2023 | $2.00 Billion | $616.00 Million | $229.25 Million | 3.25x | 8.72x |
| 2024 | $1.28 Billion | $257.35 Million | -$177.08 Million | 4.97x | N/A |
Competitor Companies of BRCTF by Market Capitalization
Companies near BioArctic AB (publ) in the global market cap rankings as of March 18, 2026.
Key companies related to BioArctic AB (publ) by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
BioArctic AB (publ) Historical Marketcap From 2022 to 2025
Between 2022 and today, BioArctic AB (publ)'s market cap moved from $2.15 Billion to $ 1.34 Billion, with a yearly change of -14.78%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $1.34 Billion | +5.08% |
| 2024 | $1.28 Billion | -36.06% |
| 2023 | $2.00 Billion | -7.02% |
| 2022 | $2.15 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of BioArctic AB (publ) was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.34 Billion USD |
| MoneyControl | $1.34 Billion USD |
| MarketWatch | $1.34 Billion USD |
| marketcap.company | $1.34 Billion USD |
| Reuters | $1.34 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.